The miniature microscope and associated data analytics will be used for assessing target engagement, pharmacodynamics, and efficacy of compounds that Lundbeck is developing for the treatment of neurologic and neuropsychiatric disorders. The technology is still new, and it is too early to say what the possibilities are.
“We are always assessing new methods to accelerate our research and development. With the ability to actually film brain activity on neuronal level I think we are exploring an interesting opportunity to gain new knowledge,” says Benjamin Hall. “The miniature microscope can depicture neurons in the brain, thereby showing where compounds interact and how they affect the brain. This has the potential to accelerate the development of treatments within brain disorders”.